The antimetastatic actions of amentoflavone by inhibition of MMPs, especially MMP-2 and MMP-9, have been believed to be involved in tumor progression, partly because of their ability to degrade collagen type IV, one of the major components of basement membranes [126]. The gene discussed is MMP9; the disease is neoplasm.